Objective: Esomeprazole is an enantiomorph of omeprazole, which inhibits gastric acid secretion more effectively than omeprazole. As proton pump inhibitors also exert an antibacterial activity, we aimed to compare esomeprazole and omeprazole for their antimicrobial activity against Helicobacter pyloriin vitro. Methods: We studied 52 H. pylori isolates obtained from gastric biopsies and inoculated onto agar plates containing the acid-converted drugs at different concentrations. The minimal concentrations that inhibited the growth of 50% and 90% of isolates were defined as MIC50 and MIC90. Results: The MIC50 and MIC90 of esomeprazole were 16 and 32 mg/L; and those of omeprazole were 32 and 64 mg/L. Overall, 63.5% of isolates showed the ...
OBJECTIVES: To compare esomeprazole-based triple therapy with esomeprazole alone for the eradication...
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a m...
Little is known about the efficacy and safety of different formulations of omeprazole-based triple t...
Objective: Esomeprazole is an enantiomorph of omeprazole, which inhibits gastric acid secretion more...
Objective: Esomeprazole is an enantiomorph of omeprazole, which inhibits gastric acid secre-tion mor...
OBJECTIVES: The reliability of the Epsilometer-test (E-Test) and the disk diffusion (DD) method in t...
Background: Bacterial resistances to antibiotics is generally considered as the most important cause...
The prevalence of resistance to clarithromycin and metronidazole has considerably increased, with a ...
Background Th e prevalence of resistance to clarithromycin and metronidazole has considerably increa...
Background: The effects of Helicobacter pylori infection associated with inhibition of gastric acid ...
Antibiotic resistances and level of acid inhibition may affect the outcome of eradicating regimens f...
PURPOSE: The objective of the present study was to determine the effectiveness of esomeprazole-based...
Background: Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti-He...
Background & Aims: The mechanism by which antimicrobial therapy against Helicobacter pylori is enhan...
Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal disea...
OBJECTIVES: To compare esomeprazole-based triple therapy with esomeprazole alone for the eradication...
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a m...
Little is known about the efficacy and safety of different formulations of omeprazole-based triple t...
Objective: Esomeprazole is an enantiomorph of omeprazole, which inhibits gastric acid secretion more...
Objective: Esomeprazole is an enantiomorph of omeprazole, which inhibits gastric acid secre-tion mor...
OBJECTIVES: The reliability of the Epsilometer-test (E-Test) and the disk diffusion (DD) method in t...
Background: Bacterial resistances to antibiotics is generally considered as the most important cause...
The prevalence of resistance to clarithromycin and metronidazole has considerably increased, with a ...
Background Th e prevalence of resistance to clarithromycin and metronidazole has considerably increa...
Background: The effects of Helicobacter pylori infection associated with inhibition of gastric acid ...
Antibiotic resistances and level of acid inhibition may affect the outcome of eradicating regimens f...
PURPOSE: The objective of the present study was to determine the effectiveness of esomeprazole-based...
Background: Rabeprazole is a new proton pump inhibitor with more potent acid suppressive and anti-He...
Background & Aims: The mechanism by which antimicrobial therapy against Helicobacter pylori is enhan...
Helicobacter pylori is the causative agent of gastritis and a co-agent in other gastroduodenal disea...
OBJECTIVES: To compare esomeprazole-based triple therapy with esomeprazole alone for the eradication...
In this randomized, multicenter trial, we evaluated the effectiveness and side effect profile of a m...
Little is known about the efficacy and safety of different formulations of omeprazole-based triple t...